Cigarette tar yields in relation to mortality from lung cancer in the cancer prevention study II prospective cohort, 1982-8

被引:100
作者
Harris, JE
Thun, MJ
Mondul, AM
Calle, EE
机构
[1] MIT, Dept Econ, Cambridge, MA 02139 USA
[2] Amer Canc Soc, Atlanta, GA 30329 USA
来源
BMJ-BRITISH MEDICAL JOURNAL | 2004年 / 328卷 / 7431期
关键词
D O I
10.1136/bmj.37936.585382.44
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To assess the risk of lung cancer in smokers of medium tar filter cigarettes compared with smokers of low tar and very low tar cigarettes. Design Analysis of the association between the tar rating of the brand of cigarette smoked in 1982 and mortality from lung cancer over the next six years. Multivariate proportional hazards analyses used to assess hazard ratios, with adjustment for age at enrolment, race, educational level, marital status, blue collar employment, occupational exposure to asbestos, intake of vegetables, citrus fruits, and vitamins, and, in analyses of current and former smokers, for age when they started to smoke and number of cigarettes smoked per day. Setting Cancer prevention study H (CPS-II). Participants 364 239 men and 576 535 women, aged greater than or equal to 30 years, who had either never smoked, were former smokers, or were currently smoking a specific brand of cigarette when they were enrolled in the cancer prevention study. Main outcome measure Death from primary cancer of the lung among participants who had never smoked, former smokers, smokers of very low tar (less than or equal to 7 mg tar/cigarette) filter, low tar (8-14 mg) filter, high tar (greater than or equal to 22 mg) non-filter brands and medium tar conventional filter brands (15-21 mg). Results Irrespective of the tar level of their current brand, all current smokers had a far greater risk of lung cancer than people who had stopped smoking or had never smoked. Compared with smokers of medium tar (15-21 mg) filter cigarettes, risk was higher among men and women who smoked high tar (greater than or equal to 22 mg) non-filter brands (hazard ratio 1.44 95% confidence interval 1.20 to 1.73, and 1.64, 1.26 to 2.15, respectively). There was no difference in risk among men who smoked brands rated as very low tar (1.17, 0.95 to 1.45) or low tar (1.02, 0.90 to 1.16) compared with those who smoked medium tar brands. The same was seen for women (0.98, 0.80 to 1.21, and 0.95, 0.82 to 1.11, respectively). Conclusion The increase in lung cancer risk is similar in people who smoke medium tar cigarettes (15-21 mg), low tar cigarettes (8-14 mg), or very low tar cigarettes (less than or equal to 7 mg). Men and women who smoke non-filtered cigarettes with tar ratings greater than or equal to 22 mg have an even higher risk of lung cancer.
引用
收藏
页码:72 / 76
页数:9
相关论文
共 82 条
[1]  
Agudo A, 2000, INT J CANCER, V88, P820, DOI 10.1002/1097-0215(20001201)88:5&lt
[2]  
820::AID-IJC21&gt
[3]  
3.0.CO
[4]  
2-J
[5]   LUNG-CANCER AND CIGARETTE-SMOKING IN WOMEN - A CASE-CONTROL STUDY IN BARCELONA (SPAIN) [J].
AGUDO, A ;
BARNADAS, A ;
PALLARES, C ;
MARTINEZ, I ;
FABREGAT, X ;
ROSELLO, J ;
ESTAPE, J ;
PLANAS, J ;
GONZALEZ, CA .
INTERNATIONAL JOURNAL OF CANCER, 1994, 59 (02) :165-169
[6]   RISKS OF LUNG-CANCER, CHRONIC-BRONCHITIS, ISCHEMIC HEART-DISEASE, AND STROKE IN RELATION TO TYPE OF CIGARETTE SMOKED [J].
ALDERSON, MR ;
LEE, PN ;
WANG, R .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1985, 39 (04) :286-293
[7]   Cigarette smoking and male lung cancer risk with special regard to type of tobacco [J].
Armadans-Gil, L ;
Vaqué-Rafart, J ;
Rosselló, J ;
Olona, M ;
Alsedà, M .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1999, 28 (04) :614-619
[8]   COMPENSATION AS A RISK FACTOR FOR LUNG-CANCER IN SMOKERS WHO SWITCH FROM NONFILTER TO FILTER CIGARETTES [J].
AUGUSTINE, A ;
HARRIS, RE ;
WYNDER, EL .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1989, 79 (02) :188-191
[9]   BLACK (AIR-CURED) AND BLOND (FLUE-CURED) TOBACCO AND CANCER RISK .6. LUNG-CANCER [J].
BENHAMOU, E ;
BENHAMOU, S .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (12) :1778-1780
[10]   LUNG-CANCER AND WOMEN - RESULTS OF A FRENCH CASE-CONTROL STUDY [J].
BENHAMOU, E ;
BENHAMOU, S ;
FLAMANT, R .
BRITISH JOURNAL OF CANCER, 1987, 55 (01) :91-95